The estimated Net Worth of Christine Siu is at least $6.19 Million dollars as of 9 December 2019. Christine Siu owns over 10,000 units of Eidos Therapeutics Inc stock worth over $5,679,099 and over the last 6 years Christine sold EIDX stock worth over $509,490.
Sign up
Christine Siu EIDX stock SEC Form 4 insiders trading
Christine has made over 8 trades of the Eidos Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Christine exercised 10,000 units of EIDX stock worth $5,900 on 9 December 2019.
The largest trade Christine's ever made was exercising 45,533 units of Eidos Therapeutics Inc stock on 19 March 2019 worth over $21,856. On average, Christine trades about 17,170 units every 29 days since 2018. As of 9 December 2019 Christine still owns at least 46,470 units of Eidos Therapeutics Inc stock.
You can see the complete history of Christine Siu stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Christine Siu's mailing address?
Christine's mailing address filed with the SEC is C/O EIDOS THERAPEUTICS, INC., 101 MONTGOMERY STREET, SUITE 2000, SAN FRANCISCO, CA, 94104.
Insiders trading at Eidos Therapeutics Inc
Over the last 6 years, insiders at Eidos Therapeutics Inc have traded over $18,169,563 worth of Eidos Therapeutics Inc stock and bought 30,345,136 units worth $349,599,962 . The most active insiders traders include Capital Management, L.P.Ra ..., Pharma, Inc. Bridge Bio, and Rajeev M. Shah. On average, Eidos Therapeutics Inc executives and independent directors trade stock every 13 days with the average trade being worth of $52,576,942. The most recent stock trade was executed by Pharma, Inc. Bridge Bio on 26 January 2021, trading 14,428,836 units of EIDX stock currently worth $1,763,348,048.
What does Eidos Therapeutics Inc's logo look like?
Complete history of Christine Siu stock trades at Eidos Therapeutics Inc
Eidos Therapeutics Inc executives and stock owners
Eidos Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Cameron Turtle,
Chief Business Officer -
William Lis,
Independent Director -
Uma Sinha,
Chief Scientific Officer, Director -
Ali Satvat,
Independent Director -
Neil Kumar,
Chief Executive Officer, Director -
Douglas Rohlen,
Independent Director -
Suzanne Hooper,
Independent Director -
Jonathan Fox,
President, Chief Medical Officer -
Franco Valle,
Senior Vice President, Finance -
Rajeev M. Shah,
Director -
Capital Management, L.P.Ra ...,
-
Christine Siu,
CFO and Secretary -
Hoyoung Huh,
Director -
Pharma, Inc. Bridge Bio,
10% owner -
Eric Aguiar,
Director